Study shows drug helps reprogram macrophage immune cells, su

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

Related Keywords

Ada Tam Srinivasan Yegnasubramanian , Lauraa Sena , Karaa Lombardo , Jelani Zarif , Kennethm Adusei , Robertd Leone , Edwardj Pearce , Barbara Slusher , Monali Praharaj , Elizabetha Thompson , Raekwona Williams , Roberte Meyerhoff , Johns Hopkins , Xiaoxu Wang , Thomasr Nirschl , Alexj Lee , Debebe Theodros , Jonathan Powell , Liang Zhao , Alokk Singh , Bloomberg Kimmel Institute For Cancer Immunotherapy , Cancer Immunology Research , National Institutes Of Health , Johns Hopkins Kimmel Cancer Center , National Institutes , Kimmel Institute , Johns Hopkins Drug , Cancer Immunology , Endowed Professor , Johns Hopkins Drug Discovery , Yifan Shen , Ada Tam , Srinivasan Yegnasubramanian , Jesse Alt , Rana Rais ,